BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31154308)

  • 1. Associations of serum liver enzyme levels and their changes over time with all-cause and cause-specific mortality in the general population: a large-scale national health screening cohort study.
    Kim KN; Joo J; Sung HK; Kim CH; Kim H; Kwon YJ
    BMJ Open; 2019 Jun; 9(5):e026965. PubMed ID: 31154308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
    Unalp-Arida A; Ruhl CE
    Hepatology; 2016 Apr; 63(4):1170-83. PubMed ID: 26663021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term mortality due to infection associated with elevated liver enzymes: a population-based cohort study.
    Oh TK; Jang ES; Song IA
    Sci Rep; 2021 Jun; 11(1):12490. PubMed ID: 34127778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of low serum alanine aminotransferase activity with mortality in the US population.
    Ruhl CE; Everhart JE
    Am J Epidemiol; 2013 Dec; 178(12):1702-11. PubMed ID: 24071009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study.
    Choi KM; Han K; Park S; Chung HS; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Park YG; Kim SM
    Sci Rep; 2018 Feb; 8(1):3764. PubMed ID: 29491346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing alcohol intake & its dose-dependent effects on liver enzymes by 24-h recall and questionnaire using NHANES 2001-2010 data.
    Agarwal S; Fulgoni VL; Lieberman HR
    Nutr J; 2016 Jun; 15(1):62. PubMed ID: 27334005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the ALT/AST ratio for predicting insulin resistance in a Korean population: A large-scale, cross-sectional cohort study.
    Han SK; Seo MJ; Lee T; Kim MY
    PLoS One; 2024; 19(5):e0303333. PubMed ID: 38758828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent and supra-additive effects of alcohol consumption, cigarette smoking, and metabolic syndrome on the elevation of serum liver enzyme levels.
    Park EY; Lim MK; Oh JK; Cho H; Bae MJ; Yun EH; Kim DI; Shin HR
    PLoS One; 2013; 8(5):e63439. PubMed ID: 23667618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The independent effects of cigarette smoking, alcohol consumption, and serum aspartate aminotransferase on the alanine aminotransferase ratio in korean men for the risk for esophageal cancer.
    Kimm H; Kim S; Jee SH
    Yonsei Med J; 2010 May; 51(3):310-7. PubMed ID: 20376881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between aspartate aminotransferase to alanine aminotransferase ratio and the risk of diabetes in Chinese prediabetic population: A retrospective cohort study.
    Wang X; Li H; Ji L; Cang J; Zhao H
    Front Public Health; 2022; 10():1045141. PubMed ID: 36684872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Relationship Between Liver Enzymes and Cardiovascular Disease: A Study in Bangladeshi Adults.
    Hasan A; Newaj A; Trisha AD; Hafsa JM; Mohanto NC; Ali N
    Endocrinol Diabetes Metab; 2024 Mar; 7(2):e00481. PubMed ID: 38494432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population.
    Qiu J; Kuang M; He S; Yu C; Wang C; Huang X; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1302322. PubMed ID: 38125795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-glutamyl transferase variability can predict the development of end-stage of renal disease: a nationwide population-based study.
    Lee DY; Han K; Yu JH; Park S; Heo JI; Seo JA; Kim NH; Yoo HJ; Kim SG; Kim SM; Choi KM; Baik SH; Park YG; Kim NH
    Sci Rep; 2020 Jul; 10(1):11668. PubMed ID: 32669624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective association of liver function biomarkers with development of hepatobiliary cancers.
    Stepien M; Fedirko V; Duarte-Salles T; Ferrari P; Freisling H; Trepo E; Trichopoulou A; Bamia C; Weiderpass E; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Fagherazzi G; Racine A; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Lagiou P; Benetou V; Trichopoulos D; Palli D; Grioni S; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Peeters PH; Lund E; Quirós JR; Nápoles OC; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Ohlsson B; Sjöberg K; Werner M; Nystrom H; Khaw KT; Key TJ; Gunter M; Cross A; Riboli E; Romieu I; Jenab M
    Cancer Epidemiol; 2016 Feb; 40():179-87. PubMed ID: 26773278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Liver Enzymes and Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study.
    Lu Y; Pike JR; Selvin E; Mosley T; Palta P; Sharrett AR; Thomas A; Loehr L; Sidney Barritt A; Hoogeveen RC; Heiss G
    J Alzheimers Dis; 2021; 79(4):1775-1784. PubMed ID: 33459646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-linear association between aspartate aminotransferase to alanine aminotransferase ratio and mortality in critically ill older patients: A retrospective cohort study.
    Yang H; Meng L; Xin S; Chang C; Zhao X; Guo B
    PLoS One; 2023; 18(11):e0293749. PubMed ID: 37917784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of liver marker enzymes and its association with type 2 diabetes mellitus in Northwest Ethiopia.
    Shibabaw T; Dessie G; Molla MD; Zerihun MF; Ayelign B
    BMC Res Notes; 2019 Oct; 12(1):707. PubMed ID: 31665087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs.
    Jang TY; Liang PC; Jun DW; Jung JH; Toyoda H; Wang CW; Yuen MF; Cheung KS; Yasuda S; Kim SE; Yoon EL; An J; Enomoto M; Kozuka R; Chuma M; Nozaki A; Ishikawa T; Watanabe T; Atsukawa M; Arai T; Hayama K; Ishigami M; Cho YK; Ogawa E; Kim HS; Shim JJ; Uojima H; Jeong SW; Ahn SB; Takaguchi K; Senoh T; Buti M; Vargas-Accarino E; Abe H; Takahashi H; Inoue K; Huang JF; Chuang WL; Yeh ML; Dai CY; Huang CF; Nguyen MH; Yu ML
    Kaohsiung J Med Sci; 2024 Feb; 40(2):188-197. PubMed ID: 37885338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.
    Alexander KS; Zakai NA; Lidofsky SD; Callas PW; Judd SE; Tracy RP; Cushman M
    PLoS One; 2018; 13(3):e0194153. PubMed ID: 29529073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver blood marker testing in UK primary care: a UK wide cohort study, 2004-2016.
    Scutt P; Ban L; Card T; Crooks CJ; Guha N; West J; Morling JR
    BMJ Open; 2022 Sep; 12(9):e058967. PubMed ID: 36167394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.